Back
Cullinan Therapeutics, Inc. CGEM · Transcripts
website
Cullinan Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for auto...109
Price11.73
Market Cap695.09 M
Float48.2 M
CountryUS
SectorHealthcare
ExchangeNASDAQ
Search in Documents